|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01875 BIODLINK-B
Nominal 
5.450 +0.220 (+4.207%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 747,645 | -31.929% | 1,098,329 | 780,629 | 442,178 | 76,325 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (3,626) | -- | 8,005 | (11,481) | (597) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | (2,495) | (6,633) | (17) | |
| Profit / (Loss) before Taxation | (100,369) | -- | 34,757 | (37,756) | (50,046) | (261,216) | |
| Taxation | 0 | -- | 0 | (1) | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 130 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (100,369) | -- | 34,757 | (37,757) | (49,916) | (261,216) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 9,676 | 48.930% | 6,497 | 2,201 | 4,337 | 1,499 |
| Depreciation & Amortisation | -- | -- | 65,417 | 43,028 | 38,039 | 34,237 |
| Directors' Emoluments | -- | -- | 7,133 | 8,974 | 8,368 | 7,196 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -14.000 | -- | 5.000 | -5.000 | -8.000 | -46.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.161 | 0.078 | 0.094 | (0.305) |
| NBV per share ($) | 0.810 | -- | 0.944 | 0.889 | 0.924 | 0.545 |
| Remarks: | Real time quote last updated: 20/03/2026 13:07 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -100,369 |
| %Change | -- |
| EPS / (LPS) | RMB -0.140 |
| NBV Per Share (¥) | RMB 0.810 |